What is Sirolimus?
Category: Prescription Drugs
Most popular types: Rapamune Rocas
Sirolimus is an immunosuppressant agent used to prevent organ rejection in renal transplants, in combination with corticosteroids and cyclosporine. It is also used to prevent rejection in heart transplant and for immunosuppression for stem cell/bone marrow transplants.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Prevent organ rejection | 190 | 22 | |
| Kidney transplant | 11 | 2 | |
| Graft versus host disease | 9 | 0 | |
| Lung transplant | 3 | 0 | |
| Heart transplant | 2 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 10 | |
| Moderate | 10 | |
| Mild | 7 | |
| None | 8 |
Commonly reported side effects and conditions associated with Sirolimus
| Side effect | Patients | Percentage |
|---|---|---|
| Acne breakout | 3 | |
| Chronic diarrhea | 3 | |
| Mouth sores (ulcers) | 3 | |
| Fluid retention (edema) | 2 | |
| High cholesterol (hypercholesterolemia) | 2 | |
| Increased lipids in blood (hyperlipidemia) | 2 |
Why patients stopped taking Sirolimus
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Doctor's advice | 17 | |
| Side effects too severe | 16 | |
| Did not seem to work | 4 | |
| Course of treatment ended | 3 | |
| Personal research | 3 | |
| Other | 2 | |
| Change in health plan coverage | 1 |
Duration
Stopped taking Sirolimus
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 7 | |
| 1 - 6 months | 9 | |
| 6 months - 1 year | 4 | |
| 1 - 2 years | 1 | |
| 2 - 5 years | 2 | |
| 5 - 10 years | 3 |
What people switch to and from
Patients started taking Sirolimus after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Tacrolimus (Prograf) | 2 | |
| Belimumab (Benlysta) | 1 | |
| Cyclosporine (Neoral) | 1 | |
| Mycophenolate mofetil (CellCept) | 1 | |
| Mycophenolic acid (Myfortic) | 1 |
Patients stopped taking Sirolimus and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Mycophenolic acid (Myfortic) | 1 | |
| Tacrolimus (Prograf) | 1 |
Last updated: